Full-Time

Scientist II

In-Vivo Pharmacology, Must have oncology experience

Posted on 7/10/2024

Scorpion Therapeutics

Scorpion Therapeutics

51-200 employees

Develops precision oncology treatments for cancer

Biotechnology
Healthcare

Junior, Mid

Boston, MA, USA

Category
Lab & Research
Life Sciences
Required Skills
Communications
Requirements
  • PhD. in pharmacology, biology or a related field
  • 1+ years of industry experience in the oncology space required
  • Experienced with cell culture and molecular biology techniques such as western blotting, qPCR and other plate-based assays and imaging techniques
  • Skilled in animal handling, compound formulation, dosing (PO/IV/SC/IP), basic surgery and necropsy techniques
  • Outstanding organizational, analytical and interpersonal skills
  • Ability to multi-task in a fast-paced environment while maintaining the highest quality of experimental execution/quality
  • Desire to contribute to teams working on challenging technical and scientific problems
  • A strong record of achievement, including publications
Responsibilities
  • Plan and coordinate in vivo experiments in-house and externally
  • Leverage organizational and communication skills to collaborate effectively with colleagues in biology and medicinal chemistry
  • Represent pharmacology on multiple project core teams
  • Analyze and present data to project teams and department meetings
  • Maintain high-quality, detailed experimental records within the ELN
  • Design and execute PK/PD/efficacy studies
Scorpion Therapeutics

Scorpion Therapeutics

View

Scorpion Therapeutics develops precision oncology treatments aimed at targeting specific cancer drivers. Their approach involves creating drugs that interact with validated cancer targets, enhancing their selectivity and safety to improve treatment efficacy. Unlike many competitors, Scorpion Therapeutics focuses on forming partnerships with larger pharmaceutical companies for the distribution of their drugs, allowing them to concentrate on research and development. Their goal is to provide effective cancer treatments that can make a significant impact on patients' lives.

Company Stage

Series C

Total Funding

$408.5M

Headquarters

Boston, Massachusetts

Founded

2020

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

3%
Simplify Jobs

Simplify's Take

What believers are saying

  • Scorpion raised $150M in Series C funding, boosting their oncology pipeline development.
  • Partnership with Pierre Fabre expands Scorpion's market reach in Europe and China.
  • Growing demand for precision oncology aligns with Scorpion's targeted therapy focus.

What critics are saying

  • Leadership changes may impact strategic direction and company morale.
  • Over-reliance on partnerships could limit Scorpion's control over product distribution.
  • Intense competition in precision oncology may affect Scorpion's market share.

What makes Scorpion Therapeutics unique

  • Scorpion Therapeutics specializes in precision medicine for cancer, focusing on small-molecule drugs.
  • Their Precision Oncology 2.0 strategy aims to redefine cancer treatment with targeted therapies.
  • Scorpion's STX-478 and STX-721 are designed as potentially best-in-class cancer inhibitors.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE